MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-32-0012773
Labcross Pharma Private Limited
Labcross Pharma Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹36.38 Lakh
▲ 770% YoY
Net loss · FY 2024
₹4,568
Net margin -0.1%
EBITDA · FY 2024
₹6,914
EBITDA margin 0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Labcross Pharma Private Limited
Data last updated:
Labcross Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 January 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2022PTC375553.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.1 Lakh. It is led by directors Rinki Yadav and Kailash Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 34 12Y Rao Chavan Ngr Veer Mata Jijabaibhosle Chembur Nearpmjoshi Colony, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2024, the company reported a revenue of ₹36.38 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4,568 (net margin -0.1%) and EBITDA of ₹6,914 (EBITDA margin 0.2%).
Labcross Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0012773). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Labcross Pharma Private Limited
CIN U24299MH2022PTC375553
Registration Number 375553
Incorporation Date 27 January 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-32-0012773
Key People
Rinki Yadav Director Kailash Yadav Director Recognitions & Rankings of Labcross Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA 34 12Y Rao Chavan Ngr Veer Mata Jijabaibhosle Chembur Nearpmjoshi Colony, Mumbai, Maharashtra, India – 400088
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
Comprehensive company report
Labcross Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Labcross Pharma Private Limited
The main business activity of Labcross Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Labcross Pharma Private Limited FY 2025 filings available
Labcross Pharma Private Limited reported revenue of ₹36.38 Lakh (up 770% YoY) for FY 2024.
Revenue · FY 2024
₹36.38 Lakh ▲ 770%
Net loss · FY 2024
₹4,568 margin -0.1%
EBITDA · FY 2024
₹6,914 margin 0.2%
Compounded Annual Growth Rate (CAGR) of Labcross Pharma Private Limited
Revenue CAGR growth
1 year
▲ 770%
EBITDA CAGR growth
1 year
▲ 169%
Revenue rose 770% in the latest year. EBITDA rose 169% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Labcross Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹6,914 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4,568 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Labcross Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.2% | •••• | •••• |
| Net Profit Margin | -0.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Labcross Pharma are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Labcross Pharma Private Limited
Labcross Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rinki Yadav | Director | 12 Sep 2023 | 3 Years 1 Months | Current |
| Kailash Yadav | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
Peer Comparison of Labcross Pharma Private Limited
Labcross Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reianshi Home Luxe Enterprise Private Limited | ₹36.5 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Mumbai, Maharashtra, India |
| Farmcraft Natural Seeds Private Limited | ₹36.47 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Aurangabad, Maharashtra, India |
| Goyal Brio Private Limited | ₹36.47 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Gurgaon, Haryana, India |
| Kskind Pharma Private Limited | ₹36.46 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Mumbai, Maharashtra, India |
| Riti Jewels Private Limited | ₹36.42 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Kolkata, West Bengal, India |
| Labcross Pharma Private Limited this company | ₹36.38 Lakh (FY 2024) | •••• | •••• | 770.0% | •••• | Mumbai, Maharashtra, India |
| Gala Enterprises Private Limited | ₹36.38 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Rohit Medical Private Limited | ₹36.37 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Kolkata, West Bengal, India |
| Bikash Textiles Private Limited | ₹36.37 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Howrah, West Bengal, India |
| Guduri Wellness Private Limited | ₹36.33 Lakh (FY 2025) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Adiva Lifestyle Private Limited | ₹36.31 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Labcross Pharma by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Labcross Pharma Private Limited
Labcross Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Labcross Pharma Private Limited
Employment history and EPFO contributions of people linked to Labcross Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Labcross Pharma Private Limited
Labcross Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Neermani Maurya ceased to be Director on 16 Sep 2023.
AGM
Labcross Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Labcross Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Neermani Maurya ceased to be Director.
Appointed
Rinki Yadav was appointed as Director.
Appointed
Kailash Yadav was appointed as Director.
Incorporation
27 Jan 2022
Labcross Pharma Private Limited was registered on 27 Jan 2022 with Roc Mumbai I & aged 4 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Labcross Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Labcross Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Labcross Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Labcross Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Labcross Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Labcross Pharma Private Limited
Labcross Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 January 2022 (4+ years old) and is registered under CIN U24299MH2022PTC375553.
Labcross Pharma reported revenue of ₹36.38 Lakh for FY 2024 (up 770% YoY).
Labcross Pharma has 2 current directors:
- Rinki Yadav - Director
- Kailash Yadav - Director
Labcross Pharma reported a net loss of ₹4,568 (net margin -0.1%) and EBITDA of ₹6,914 (EBITDA margin 0.2%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Labcross Pharma is U24299MH2022PTC375553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Labcross Pharma was incorporated on 27 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Labcross Pharma by revenue are Reianshi Home Luxe Enterprise Private Limited, Farmcraft Natural Seeds Private Limited, Goyal Brio Private Limited, Kskind Pharma Private Limited, Riti Jewels Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Neermani Maurya ceased to be Director on 16 Sep 2023. Rinki Yadav was appointed as Director on 12 Sep 2023. Kailash Yadav was appointed as Director on 27 Jan 2022.
Yes, Labcross Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0012773).
The registered office of Labcross Pharma is at A 34 12Y Rao Chavan Ngr Veer Mata Jijabaibhosle Chembur Nearpmjoshi Colony, Mumbai, Maharashtra, India – 400088.
Labcross Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.1 Lakh.